NLGIA
MDCO

Nippon Life Global Investors Americas’s Medicines Co MDCO Stock Holding History

Nippon Life Global Investors Americas’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,700
Closed -$646K – 159
2014
Q1 		$646K Sell
22,700
-79,780
-78% -$2.64M 0.06% 151
2013
Q4 		$3.96M Buy
102,480
+11,680
+13% +$418K 0.39% 100
2013
Q3 		$3.04M Buy
90,800
+59,400
+189% +$1.89M 0.33% 106
2013
Q2 		$966K Buy
+31,400
New +$1.05M 0.11% 127

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Nippon Life Global Investors Americas's MDCO Position: Q2 2014 in Review

Nippon Life Global Investors Americas sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 22,700 shares — an estimated $646K sold.

Nippon Life Global Investors Americas first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $3.96M in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Nippon Life Global Investors Americas reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 22,700 Medicines Co shares in Q2 2014, an estimated $646K.
  • Nippon Life Global Investors Americas first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Nippon Life Global Investors Americas's Medicines Co position peaked at $3.96M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2014, filed 13 Aug 2014.